Deutsche Bank raised the firm’s price target on Emerson (EMR) to $140 from $136 and keeps a Buy rating on the shares. While the “modest” 3% Q4 core adjusted segment EBITA beat and fiscal 2025 guidance positioned 1% above consensus “was certainly helpful,” the bulk of the share rally can be attributed to Emerson’s strategic announcements, the analyst tells investors in a research note. The firm says the company announced three key strategic actions that will complete its portfolio transformation to an industrial technology leader delivering advanced automation solutions. It believes the “new and improved” Emerson is not reflected in the stock’s valuation.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Boeing union to end strike, Palantir reports Q3 beat: Morning Buzz
- Early notable gainers among liquid option names on November 5th
- Morning Movers: GlobalFoundries and Apollo Global gain following Q3 results
- Emerson reports Q4 adjusted EPS $1.48, consensus $1.47
- Emerson proposes to acquire Aspen Technology for $240 per share in cash